LNK01001 Capsule

· Lynk Pharmaceuticals Co., Ltd

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for LNK01001 Capsule, covering 2026-01-14 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 3 Study of LNK01001 Capsule in Subjects With Moderate to Severe Atopic Dermatitis. [Phase 3]